孕期意外接种四价HPV疫苗与不良妊娠结局及婴儿死亡率的关联
结果显示孕期接种四价HPV疫苗未显著增加自然流产、死产(调整OR=0.96,95%CI:0.57-1.61)或婴儿死亡(调整HR=0.94,95%CI:0.53-1.67)风险。
要点
- 孕期意外接种四价HPV疫苗未增加自然流产风险。
- 孕期接种与死产无关联(调整OR=0.96,95%CI:0.57-1.61)。
- 孕期接种与婴儿死亡无关联(调整HR=0.94,95%CI:0.53-1.67)。
核心结论
- 孕期意外接种四价HPV疫苗未增加自然流产、死产或婴儿死亡风险。
研究设计与样本
- 基于丹麦全国健康登记的人群研究,纳入1975-1992年出生女性的妊娠,暴露窗口为受孕前4周至妊娠22周(自然流产)或至分娩(死产和婴儿死亡)。
- 自然流产分析纳入522705次妊娠(7487次孕期接种至少一剂),死产分析纳入351878次分娩(5262次孕期接种),婴儿死亡分析纳入350739例活产(5245次孕期接种)。
- 自然流产采用时间事件模型,死产采用逻辑回归,婴儿死亡采用Cox回归。
主要发现
- 孕期接种女性与未接种女性相比,自然流产率无显著升高。
- 孕期接种与死产无关联(调整OR=0.96,95%CI:0.57-1.61)。
- 孕期接种与婴儿死亡无关联(调整HR=0.94,95%CI:0.53-1.67)。
- 二次分析显示接种剂次数和接种时间(孕前或孕期)与自然流产风险增加无关。
临床怎么用
- 孕期意外接种四价HPV疫苗时,可依据本证据向孕妇说明未观察到自然流产、死产或婴儿死亡风险增加。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Few studies have studied the association between unintended human papillomavirus (HPV) vaccination and adverse pregnancy outcomes. This study set out to determine the association between HPV vaccination during pregnancy and subsequent risk of spontaneous abortion, stillbirth, and one-year infant mortality. METHODS: Population-based study including all pregnancies in Denmark (October 2006-December 2014) among women born 1975-1992. From nationwide health registries using the personal identification numbers, we obtained information on HPV vaccination, pregnancy outcomes, and infant mortality. The exposure window went from four weeks before conception date until 22 weeks of gestation for the outcome spontaneous abortion, and until birth for stillbirth and infant mortality outcomes. In the analyses of spontaneous abortion, we used time to event models, for stillbirth logistic regression models, and for infant mortality Cox regression was applied. RESULTS: We included 522,705 pregnancies for the outcome spontaneous abortion (7487 exposed to at least one dose during pregnancy); 351,878 births (5262 exposed to at least one dose during pregnancy) for the stillbirth; and 350,739 live births (5245 exposed to at least one dose during pregnancy) for infant mortality. No significantly increased rate of spontaneous abortion among women vaccinated during pregnancy compared with unvaccinated women was found. In addition, we found no association between HPV vaccination during pregnancy and stillbirth (adjusted odds ratio = 0.96 [95% CI: 0.57-1.61]), or infant mortality (adjusted hazard ratio = 0.94 [95% CI: 0.53-1.67]). A secondary analysis showed no association between number of doses and timing of administration (i.e. vaccination before or during pregnancy) and an increased risk of spontaneous abortion. CONCLUSION: We found no increased risk of spontaneous abortion, stillbirth, or infant mortality following unintended HPV vaccination during pregnancy.
引用
- Faber MT, Duun-Henriksen AK, Dehlendorff C, et al. Adverse pregnancy outcomes and infant mortality after quadrivalent HPV vaccination during pregnancy. Vaccine. 2018. PMID: 30503078. doi:10.1016/j.vaccine.2018.11.030
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。